Similar articles

• Is a blood pressure rise the only deleterious off-target effect of cholesterol ester transfer protein inhibitors?

  Miura S, Saku K. Miura S, et al. J Hypertens. 2010 Aug;28(8):1614-6. doi: 10.1097/HJH.0b013e32833c575b. J Hypertens. 2010. PMID: 20647856 No abstract available.
• Effect of cholesteryl ester transfer protein inhibitor on vitamin E transport should be studied.

  Masterjohn C. Masterjohn C. Am Heart J. 2009 Jul;158(1):e11; author reply e13. doi: 10.1016/j.ahj.2009.05.004. Am Heart J. 2009. PMID: 19540377 No abstract available.
• New drug fizzles at raising HDL. Tried-and-true strategies are still excellent ways to boost good cholesterol.

  [No authors listed] [No authors listed] Harv Heart Lett. 2007 Mar;17(7):1-2. Harv Heart Lett. 2007. PMID: 17378073 No abstract available.
• ["The lower LDL cholesterol levels, the better" still valid. Negative/neutral conclusions of three studies on statins do not change the clinical practice].

  Olsson AG, Nilsson PM. Olsson AG, et al. Lakartidningen. 2009 Mar 18-24;106(12):854-7. Lakartidningen. 2009. PMID: 19452786 Review. Swedish. No abstract available.
• Is high HDL cholesterol always good?

  Olsson AG. Olsson AG. Ann Med. 2009;41(1):11-8. doi: 10.1080/07853890802609534. Ann Med. 2009. PMID: 19085339 Review.